SterRx Recalls 240 Lots of 12 Products

SterRx is recalling about 240 lots of 12 different products. The recall is being made because of due equipment and process issues that could lead to a lack of sterility. To date, SterRx has not received reports of adverse events associated.

These lots were distributed between December 2020 and October 2021.

The products impacted include:

• 1mg/mL Midazolam in 0.9% Sodium Chloride
• Fentanyl in 0.9% Sodium Chloride
• 1mg/mL Morphine Sulfate in 0.9% Sodium Chloride
• 1mg/mL Morphine Sulfate in 5% Dextrose
• 125mg Diltiazem HCL in 0.7% Sodium Chloride
• 125mg Diltiazem HCL in 5% Dextrose
• Norepinephrine in 0.9% Sodium Chloride
• Norepinephrine in 5% Dextrose
• Epinephrine in 0.9% Sodium Chloride
• Phenylephrine in 0.9% Sodium Chloride
• 150mEq Sodium Bicarbonate in 5% Dextrose
• 200mg Succinylcholine Chloride in 0.9% Sodium Chloride

Those with questions should call (518) 324-7983 or email Recall@sterrx.com.